These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10703747)

  • 1. Are intestinal tumours in Apc+/-mice a suitable model of colorectal carcinoma in man?
    Lojda Z; Havránková E; Sovová V; Sloncová E; Fric P
    Gen Physiol Biophys; 1999 Sep; 18(3):311-6. PubMed ID: 10703747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.
    Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK
    Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucrase-isomaltase and other brush border glycosidases in colorectal tumors.
    Lojda Z; Fric P
    Acta Histochem; 1996 Jul; 98(3):285-93. PubMed ID: 8863857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
    Ahn B; Ohshima H
    Cancer Res; 2001 Dec; 61(23):8357-60. PubMed ID: 11731407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.
    Paulsen JE; Alexander J
    Anticancer Res; 2001; 21(5):3281-4. PubMed ID: 11848484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of guanylin is downregulated in mouse and human intestinal adenomas.
    Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB
    Biochem Biophys Res Commun; 2000 Jun; 273(1):225-30. PubMed ID: 10873591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.
    Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J
    Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice.
    Shi L; Itoh F; Itoh S; Takahashi S; Yamamoto M; Kato M
    Oncogene; 2008 May; 27(23):3265-73. PubMed ID: 18246128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apc mice: models, modifiers and mutants.
    McCart AE; Vickaryous NK; Silver A
    Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
    Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
    J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.
    Blanc V; Henderson JO; Newberry RD; Xie Y; Cho SJ; Newberry EP; Kennedy S; Rubin DC; Wang HL; Luo J; Davidson NO
    Cancer Res; 2007 Sep; 67(18):8565-73. PubMed ID: 17875695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine metabolism and tumorigenesis in the Apc(Min/+) mouse.
    Berger FG; Kramer DL; Porter CW
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):336-9. PubMed ID: 17371273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
    Rudolph KL; Millard M; Bosenberg MW; DePinho RA
    Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice.
    Klein IK; Ritland SR; Burgart LJ; Ziesmer SC; Roche PC; Gendler SJ; Karnes WE
    Cancer Res; 2000 Apr; 60(8):2077-80. PubMed ID: 10786662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.